Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM)

NCT02858869 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02858869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02858869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM)
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
October 4, 2016
Completion date
October 28, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma of unknown primary, metastatic malignant neoplasm in the brain, metastatic melanoma, mucosal melanoma, ocular melanoma, stage iv non-small cell lung cancer, stage iv skin melanoma